CN115671001A - Whitening and skin-brightening essence and preparation method thereof - Google Patents
Whitening and skin-brightening essence and preparation method thereof Download PDFInfo
- Publication number
- CN115671001A CN115671001A CN202211470574.6A CN202211470574A CN115671001A CN 115671001 A CN115671001 A CN 115671001A CN 202211470574 A CN202211470574 A CN 202211470574A CN 115671001 A CN115671001 A CN 115671001A
- Authority
- CN
- China
- Prior art keywords
- skin
- whitening
- extract
- portions
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 81
- 238000005282 brightening Methods 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000284 extract Substances 0.000 claims abstract description 91
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 48
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 48
- 241000736199 Paeonia Species 0.000 claims abstract description 35
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 35
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 28
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 26
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 26
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 24
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 24
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 24
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 18
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 18
- 239000003906 humectant Substances 0.000 claims abstract description 16
- -1 skin conditioner Chemical compound 0.000 claims abstract description 12
- 239000009724 Salvia extract Substances 0.000 claims abstract description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 21
- 229940112950 sage extract Drugs 0.000 claims description 18
- 235000020752 sage extract Nutrition 0.000 claims description 18
- 235000006708 antioxidants Nutrition 0.000 claims description 17
- 239000004475 Arginine Substances 0.000 claims description 15
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 15
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 15
- 235000009697 arginine Nutrition 0.000 claims description 15
- 239000011668 ascorbic acid Substances 0.000 claims description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims description 15
- 229960005070 ascorbic acid Drugs 0.000 claims description 15
- 239000004359 castor oil Substances 0.000 claims description 15
- 235000019438 castor oil Nutrition 0.000 claims description 15
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 15
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 15
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 15
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 14
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 14
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 14
- 229930064664 L-arginine Natural products 0.000 claims description 14
- 235000014852 L-arginine Nutrition 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 14
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 14
- 229940114123 ferulate Drugs 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 206010040829 Skin discolouration Diseases 0.000 claims description 4
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 3
- 229920002498 Beta-glucan Polymers 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 3
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 3
- 229940011399 escin Drugs 0.000 claims description 3
- 229930186222 escin Natural products 0.000 claims description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 3
- 150000002339 glycosphingolipids Chemical class 0.000 claims description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 3
- 229940101267 panthenol Drugs 0.000 claims description 3
- 235000020957 pantothenol Nutrition 0.000 claims description 3
- 239000011619 pantothenol Substances 0.000 claims description 3
- 229920000223 polyglycerol Polymers 0.000 claims description 3
- 229940051841 polyoxyethylene ether Drugs 0.000 claims description 3
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- ZQTUNIWBUQUKAM-UHFFFAOYSA-N [3-[2-(1h-imidazol-1-ium-4-yl)ethylamino]-3-oxopropyl]azanium;dichloride Chemical compound Cl.Cl.NCCC(=O)NCCC1=CN=CN1 ZQTUNIWBUQUKAM-UHFFFAOYSA-N 0.000 claims 1
- 229940033353 decarboxy carnosine hydrochloride Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 235000002020 sage Nutrition 0.000 abstract description 16
- 240000007164 Salvia officinalis Species 0.000 abstract description 11
- 235000002912 Salvia officinalis Nutrition 0.000 abstract description 11
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 239000000686 essence Substances 0.000 description 43
- 210000003491 skin Anatomy 0.000 description 40
- 230000000052 comparative effect Effects 0.000 description 19
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- HIXYEIRACBUSON-FJXQXJEOSA-N (2s)-2-(3-aminopropanoylamino)-3-(1h-imidazol-5-yl)propanoic acid;hydrochloride Chemical compound Cl.NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 HIXYEIRACBUSON-FJXQXJEOSA-N 0.000 description 12
- 108010087806 Carnosine Proteins 0.000 description 12
- 229940070763 carnosine hydrochloride Drugs 0.000 description 12
- 229940042585 tocopherol acetate Drugs 0.000 description 11
- 238000012360 testing method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 244000236658 Paeonia lactiflora Species 0.000 description 4
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 241000219784 Sophora Species 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 235000017784 Mespilus germanica Nutrition 0.000 description 2
- 244000182216 Mimusops elengi Species 0.000 description 2
- 235000000560 Mimusops elengi Nutrition 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 241001295692 Pyracantha fortuneana Species 0.000 description 2
- 235000007837 Vangueria infausta Nutrition 0.000 description 2
- SHOKSIZSCQFIRY-UHFFFAOYSA-N [3-(2-tert-butyl-2-hydroxy-4,4-dimethyl-3-phenylpentanoyl)oxy-2,2-bis[(2-tert-butyl-2-hydroxy-4,4-dimethyl-3-phenylpentanoyl)oxymethyl]propyl] 2-tert-butyl-2-hydroxy-4,4-dimethyl-3-phenylpentanoate Chemical compound C=1C=CC=CC=1C(C(C)(C)C)C(O)(C(C)(C)C)C(=O)OCC(COC(=O)C(O)(C(C=1C=CC=CC=1)C(C)(C)C)C(C)(C)C)(COC(=O)C(O)(C(C=1C=CC=CC=1)C(C)(C)C)C(C)(C)C)COC(=O)C(O)(C(C)(C)C)C(C(C)(C)C)C1=CC=CC=C1 SHOKSIZSCQFIRY-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- VPFMJGCHDCVATR-UHFFFAOYSA-N 2,3,4,5,6-pentabromoaniline Chemical compound NC1=C(Br)C(Br)=C(Br)C(Br)=C1Br VPFMJGCHDCVATR-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000632227 Antenoron Species 0.000 description 1
- 241001313855 Bletilla Species 0.000 description 1
- KNFLNGRLKALWRF-LDXSYGEZSA-N CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 KNFLNGRLKALWRF-LDXSYGEZSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000143590 Salvia chinensis Species 0.000 description 1
- 235000007154 Salvia chinensis Nutrition 0.000 description 1
- 235000005794 Salvia japonica Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
Abstract
The invention discloses a whitening and skin-brightening essence and a preparation method thereof, belonging to the technical field of cosmetics and comprising the following components: solubilizer, humectant, nicotinamide, p-hydroxyacetophenone, skin conditioner, 1, 2-hexanediol, peony extract, sophora flavescens extract, salvia extract, tranexamic acid, pH regulator, antioxidant, 1, 3-butanediol and water. The whitening essence provided by the invention has an excellent whitening and skin brightening effect, and the components in the whitening and skin brightening essence are reasonably compatible and mutually influenced and interact to act from a plurality of whitening angles, wherein the peony extract, the sophora flavescens extract and the salvia officinalis extract have a synergistic effect in whitening.
Description
Technical Field
The invention relates to the technical field of cosmetics, and particularly relates to a whitening and skin-brightening essence and a preparation method thereof.
Background
With the increasing emphasis on skin problems such as pigmentation, freckles and the like, whitening becomes an indispensable part of people's life, and various whitening cosmetics are produced to meet people's preference and pursuit for whitening skin. The traditional whitening agents such as hydroquinone, lead powder and the like have excellent whitening effect, but have large cytotoxicity and strong side effect, and cannot meet the safety required by modern people when whitening is pursued.
CN112807256A discloses a whitening composition and application thereof in cosmetics, wherein the whitening composition comprises the following components in parts by mass: 0.2 to 2 parts of peony root extract, 1 to 2 parts of VC ethyl ether and 2 to 5 parts of nonapeptide-1. It is disclosed that the extract of the root of Paeonia lactiflora can inhibit the activity of tyrosinase, thereby inhibiting the production of melanin.
CN108721179A discloses a plant extract composition with whitening effect, a preparation method and a use thereof, wherein the composition is composed of extracts of plants such as radix sophorae flavescentis, bamboo leaves, pyracantha fortuneana fruits and medlar; the content of each plant extract is as follows according to weight percentage: 1 to 34 percent of lightyellow sophora root, 1 to 34 percent of bamboo leaf, 1 to 34 percent of pyracantha fortuneana fruit and 1 to 34 percent of medlar, and discloses that alkaloid components in the lightyellow sophora root can inhibit the activity of tyrosinase in melanocytes, can inhibit the transfer of melanin from the melanocytes to cuticle, and simultaneously has the relieving effect of resisting external stimulation on skin, thereby having the effects of whitening and calming the skin.
CN104013560A discloses a whitening traditional Chinese medicine composition, which comprises the following raw materials in parts by weight: 30 to 50 percent of angelica, 25 to 35 percent of common bletilla pseudobulb, 10 to 15 percent of longhairy antenoron herb, 10 to 15 percent of salvia officinalis and 5 to 10 percent of liquorice. It discloses that sage is bitter, pungent and neutral in taste, and has the effects of promoting blood circulation, removing blood stasis, dispelling pathogenic wind, promoting diuresis, removing toxic substance and resolving food stagnation; the liquorice is used for harmonizing the effects of the medicines, has sweet and mild taste, enters spleen, stomach and lung channels, contains abundant glycyrrhetinic acid, licoflavone and other effective whitening and anti-free radical components, and has the effects of tonifying spleen and qi, clearing heat and removing toxicity, whitening and removing freckles.
Although the prior art discloses that the peony, the sophora flavescens and the sage have the whitening effect, the prior art does not use the combination of the peony, the sophora flavescens and the sage for whitening.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provides the whitening and skin-brightening essence and the preparation method thereof.
In order to achieve the purpose, the invention adopts the technical scheme that:
the whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 to 0.25 portion of solubilizer, 0.1 to 0.4 portion of humectant, 0.2 to 0.6 portion of nicotinamide, 0.3 to 0.6 portion of p-hydroxyacetophenone, 0.4 to 1 portion of skin conditioner, 0.4 to 1 portion of 1, 2-hexanediol, 0.4 to 1 portion of peony extract, 0.5 to 1.2 portions of radix sophorae flavescentis extract, 0.5 to 1.2 portions of sage extract, 0.5 to 2 portions of tranexamic acid, 0.5 to 1.2 portions of pH regulator, 1 to 4 portions of antioxidant, 4 to 10 portions of 1, 3-butanediol and 70 to 85 portions of water.
As a preferred embodiment of the invention, the whitening and skin-brightening essence comprises the following components in parts by mass: 0.15 to 0.25 portion of solubilizer, 0.2 to 0.4 portion of humectant, 0.3 to 0.6 portion of nicotinamide, 0.4 to 0.6 portion of p-hydroxyacetophenone, 0.4 to 0.8 portion of skin conditioner, 0.5 to 1 portion of 1, 2-hexanediol, 0.5 to 1 portion of peony extract, 0.6 to 1.2 portions of radix sophorae flavescentis extract, 0.8 to 1.2 portions of sage extract, 0.5 to 1.5 portions of tranexamic acid, 0.8 to 1.2 portions of pH regulator, 2 to 4 portions of antioxidant, 4 to 8 portions of 1, 3-butanediol and 75 to 85 portions of water.
As a preferred embodiment of the invention, the whitening and skin-brightening essence comprises the following components in parts by mass: 0.2 part of solubilizer, 0.3 part of humectant, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.7 part of skin conditioner, 0.8 part of 1, 2-hexanediol, 0.8 part of peony extract, 0.8 part of sophora flavescens extract, 1 part of sage extract, 1 part of tranexamic acid, 1 part of pH regulator, 3 parts of antioxidant, 6 parts of 1, 3-butanediol and 83.4 parts of water.
As a preferred embodiment of the present invention, the solubilizer includes at least one of PEG-40 hydrogenated castor oil, polyglycerol fatty acid ester, fatty alcohol polyoxyethylene ether, polyoxyethylene sorbitan fatty acid ester.
As a preferred embodiment of the present invention, the skin conditioner comprises at least one of tocopherol acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, panthenol, biosaccharide gum-1, oligopeptide-1, tripeptide-1 copper, palmitoyl pentapeptide-4, escin, and glycosphingolipids.
As a preferred embodiment of the present invention, the pH adjusting agent includes at least one of arginine, triethanolamine, citric acid, and sodium citrate.
As a preferred embodiment of the present invention, the antioxidant comprises at least one of ascorbic acid, glycerol glucoside, tributyl citrate, pentaerythritol tetrakis (bis-tert-butyl hydroxyhydrocinnamate), butyether-3.
As a preferred embodiment of the present invention, the humectant comprises at least one of hydrolyzed sodium hyaluronate, glycerin, propylene glycol, oat beta-glucan, caprylyl glycol, and ethylhexylglycerin.
The invention also provides a preparation method of the whitening and skin-brightening essence, which comprises the following steps:
(1) Adding nicotinamide, humectant, p-hydroxyacetophenone, 1, 2-hexanediol, skin conditioner, tranexamic acid, antioxidant and 1, 3-butanediol into water, and stirring uniformly at 70-85 ℃;
(2) Cooling to 40-50 ℃, adding a solubilizer, a peony extract, a sophora flavescens extract, a salvia extract and a pH regulator, uniformly stirring, and cooling to obtain the whitening and skin brightening essence.
As a preferred embodiment of the present invention, the stirring rate in the step (1) is 400 to 1000rpm;
the stirring speed in the step (1) is 400-1000 rpm.
The invention has the beneficial effects that: (1) The whitening essence provided by the invention has an excellent whitening and skin brightening effect, and the components in the whitening and skin brightening essence are reasonably compatible and mutually influenced and interact to act from a plurality of whitening angles, wherein the peony extract, the sophora flavescens extract and the salvia officinalis extract have a synergistic effect in whitening.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are a part of the embodiments of the present invention, but not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without inventive step based on the embodiments of the present invention, are within the scope of protection of the present invention.
In the present invention, the technical features described in the open type include a closed technical solution including the listed features, and also include an open technical solution including the listed features.
In the present invention, the numerical intervals are regarded as continuous, and include the minimum and maximum values of the range and each value between the minimum and maximum values, unless otherwise specified. Further, when a range refers to an integer, each integer between the minimum and maximum values of the range is included. Further, when multiple range describing features or characteristics are provided, the ranges may be combined. In other words, unless otherwise indicated, all ranges disclosed herein are to be understood to encompass any and all subranges subsumed therein.
In the present invention, the specific dispersion and stirring treatment method is not particularly limited.
The reagents or instruments used in the present invention are not indicated by manufacturers, and are all conventional products commercially available.
Aims to solve the problem that the cosmetic in the prior art has poor whitening and skin brightening effects.
The embodiment of the invention provides a whitening and skin-brightening essence which comprises the following components in parts by mass: 0.1 to 0.25 portion of solubilizer, 0.1 to 0.4 portion of humectant, 0.2 to 0.6 portion of nicotinamide, 0.3 to 0.6 portion of p-hydroxyacetophenone, 0.4 to 1 portion of skin conditioner, 0.4 to 1 portion of 1, 2-hexanediol, 0.4 to 1 portion of peony extract, 0.5 to 1.2 portions of radix sophorae flavescentis extract, 0.5 to 1.2 portions of sage extract, 0.5 to 2 portions of tranexamic acid, 0.5 to 1.2 portions of pH regulator, 1 to 4 portions of antioxidant, 4 to 10 portions of 1, 3-butanediol and 70 to 85 portions of water.
The raw materials are subjected to component mixing according to the specific mass parts to obtain the essence with excellent whitening and skin brightening effects, the components in the essence are reasonably compatible, the components are mutually influenced and interacted, and the effect is performed from a plurality of whitening angles, wherein the peony extract, the sophora flavescens extract and the salvia officinalis extract have synergistic effects in the whitening aspect.
The essence mainly comprises the following components with the effects of whitening and brightening the skin:
nicotinamide: plays a role in the transport process of melanin.
Tranexamic acid: inhibiting factor group for enhancing melanin, completely blocking melanin formation path due to ultraviolet irradiation, preventing black spot from thickening and enlarging, and effectively preventing skin pigmentation.
Peony (PAEONIA LACTIFLORA) extract: the peony extract has the functions of activating skin and resisting aging, can be used for anti-aging cosmetics, and has better moisturizing capability, the peony extract can effectively inhibit the activity of the tyrosinase, can effectively inhibit the generation of melanin and reduce skin pigmentation.
Radix Sophorae Flavescentis (Sophora flavescenes) extract: the sophora flavescens extract contains various active ingredients, such as: matrine, oxymatrine, etc., and radix Sophorae Flavescentis extract has antibacterial and antiinflammatory effects; the sophora flavescens extract can effectively promote the generation of collagen, has the effects of resisting aging and preserving moisture, can remove toxin impurities in skin, has an obvious relieving effect on leucocyte reduction caused by cyclophosphamide, X-ray and cobalt ray irradiation, can effectively inhibit the activity of tyrosinase and the transfer of melanin, and can inhibit the deposition of melanin.
Extract of sage (SALVIA JAPONICA): the sage has excellent anti-inflammatory and sun-screening effects, and can effectively inhibit melanin deposition and improve skin brightness.
The invention takes nicotinamide and tranexamic acid as basic whitening components, and the effects are performed from a plurality of whitening angles by adding the peony extract, the sophora flavescens extract and the salvia extract, so that the whitening effect is obviously improved.
In one embodiment, the whitening and skin-brightening essence comprises the following components in parts by mass: 0.15 to 0.25 portion of solubilizer, 0.2 to 0.4 portion of humectant, 0.3 to 0.6 portion of nicotinamide, 0.4 to 0.6 portion of p-hydroxyacetophenone, 0.4 to 0.8 portion of skin conditioner, 0.5 to 1 portion of 1, 2-hexanediol, 0.5 to 1 portion of peony extract, 0.6 to 1.2 portions of radix sophorae flavescentis extract, 0.8 to 1.2 portions of sage extract, 0.5 to 1.5 portions of tranexamic acid, 0.8 to 1.2 portions of pH regulator, 2 to 4 portions of antioxidant, 4 to 8 portions of 1, 3-butanediol and 75 to 85 portions of water.
In one embodiment, the whitening and skin-brightening essence comprises the following components in parts by mass: 0.2 part of solubilizer, 0.3 part of humectant, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.7 part of skin conditioner, 0.8 part of 1, 2-hexanediol, 0.8 part of peony extract, 0.8 part of sophora flavescens extract, 1 part of sage extract, 1 part of tranexamic acid, 1 part of pH regulator, 3 parts of antioxidant, 6 parts of 1, 3-butanediol and 83.4 parts of water. Especially, the whitening and skin brightening effects are best under the dosage.
Illustratively, the solubilizer comprises at least one of PEG-40 hydrogenated castor oil, polyglycerol fatty acid ester, fatty alcohol polyoxyethylene ether and polyoxyethylene sorbitan fatty acid ester.
More specifically, in the whitening and skin brightening essence of the invention, the solubilizer preferably adopts PEG-40 hydrogenated castor oil. The solubilizer can improve the compatibility of the whole formula system and is convenient for the stable dissolution of the powdery substance in the system.
Illustratively, the skin conditioning agent comprises at least one of tocopherol acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, panthenol, biosaccharide gum-1, oligopeptide-1, tripeptide-1 copper, palmitoyl pentapeptide-4, escin, glycosphingolipids.
Illustratively, the pH adjuster includes at least one of arginine, triethanolamine, citric acid, and sodium citrate.
More specifically, in the whitening and skin-brightening essence of the invention, arginine is preferably used as the pH regulator.
Illustratively, the antioxidant comprises at least one of ascorbic acid, glycerol glucoside, tributyl citrate, pentaerythritol tetrakis (di-tert-butyl hydroxyhydrocinnamate), and butyether-3.
More specifically, in the whitening and skin-brightening essence of the invention, ascorbic acid is preferably used as the antioxidant.
Illustratively, the humectant comprises at least one of hydrolyzed sodium hyaluronate, glycerin, propylene glycol, oat beta glucan, caprylyl glycol, and ethylhexylglycerin.
More specifically, in the whitening and skin-brightening essence of the invention, hydrolyzed sodium hyaluronate is preferably used as the antioxidant.
The invention also provides a preparation method of the whitening and skin-brightening essence, which comprises the following steps:
(1) Adding nicotinamide, humectant, p-hydroxyacetophenone, 1, 2-hexanediol, skin conditioner, tranexamic acid, antioxidant and 1, 3-butanediol into water, and stirring uniformly at 70-85 ℃;
(2) Cooling to 40-50 ℃, adding a solubilizer, a peony extract, a sophora flavescens extract, a salvia extract and a pH regulator, uniformly stirring, and cooling to obtain the whitening and skin brightening essence.
As a preferred embodiment of the present invention, the stirring rate in the step (1) is 400 to 1000rpm;
the stirring speed in the step (1) is 400-1000 rpm.
The following examples are provided to facilitate an understanding of the invention. These examples are not provided to limit the scope of the claims.
Example 1
The whitening and skin brightening essence comprises the following components in parts by mass: 0.1 part of tocopherol acetate, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of L-arginine ferulate, 0.2 part of decarboxylated carnosine hydrochloride, 0.2 part of PEG-40 hydrogenated castor oil, 0.3 part of hydrolyzed sodium hyaluronate, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 0.8 part of peony extract, 0.8 part of sophora flavescens extract, 1 part of sage extract, 1 part of tranexamic acid, 1 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.4 parts of water.
The preparation method of the whitening and skin-brightening essence comprises the following steps:
(1) Adding nicotinamide, hydrolyzed sodium hyaluronate, p-hydroxyacetophenone, 1, 2-hexanediol, tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, tranexamic acid, ascorbic acid and 1, 3-butanediol into water, and stirring at 80 deg.C and 800 rpm;
(2) Cooling to 45 deg.C, adding PEG-40 hydrogenated castor oil, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, and arginine, stirring at 800rpm, and cooling to obtain the skin whitening essence.
Example 2
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 part of tocopherol acetate, 0.1 part of dipotassium glycyrrhizinate, 0.1 part of L-arginine ferulate, 0.1 part of decarboxylated carnosine hydrochloride, 0.1 part of PEG-40 hydrogenated castor oil, 0.4 part of hydrolyzed sodium hyaluronate, 0.2 part of nicotinamide, 0.6 part of p-hydroxyacetophenone, 0.4 part of 1, 2-hexanediol, 0.4 part of peony extract, 1.2 parts of sophora flavescens extract, 0.8 part of sage extract, 1 part of tranexamic acid, 0.8 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 84.7 parts of water.
The preparation method of the whitening and skin-brightening essence comprises the following steps:
(1) Adding nicotinamide, hydrolyzed sodium hyaluronate, p-hydroxyacetophenone, 1, 2-hexanediol, tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, tranexamic acid, ascorbic acid and 1, 3-butanediol into water, and stirring at 80 deg.C and 800 rpm;
(2) Cooling to 45 deg.C, adding PEG-40 hydrogenated castor oil, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, and arginine, stirring at 800rpm, and cooling to obtain the essence with skin whitening and brightening effects.
Example 3
The whitening and skin brightening essence comprises the following components in parts by mass: 0.1 part of tocopherol acetate, 0.3 part of dipotassium glycyrrhizinate, 0.3 part of L-arginine ferulate, 0.3 part of decarboxylated carnosine hydrochloride, 0.25 part of PEG-40 hydrogenated castor oil, 0.1 part of hydrolyzed sodium hyaluronate, 0.6 part of nicotinamide, 0.3 part of p-hydroxyacetophenone, 1 part of 1, 2-hexanediol, 0.9 part of peony extract, 0.5 part of sophora flavescens extract, 1 part of sage extract, 1 part of tranexamic acid, 1.2 parts of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.15 parts of water.
The preparation method of the whitening and skin-brightening essence comprises the following steps:
(1) Adding nicotinamide, hydrolyzed sodium hyaluronate, p-hydroxyacetophenone, 1, 2-hexanediol, tocopherol acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, tranexamic acid, ascorbic acid and 1, 3-butanediol into water, and stirring uniformly at the rotation speed of 800rpm at the temperature of 80 ℃;
(2) Cooling to 45 deg.C, adding PEG-40 hydrogenated castor oil, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, and arginine, stirring at 800rpm, and cooling to obtain the essence with skin whitening and brightening effects.
Example 4
The whitening and skin brightening essence comprises the following components in parts by mass: 0.15 part of tocopherol acetate, 0.2 part of dipotassium glycyrrhizinate, 0.25 part of L-arginine ferulate, 0.25 part of decarboxylated carnosine hydrochloride, 0.15 part of PEG-40 hydrogenated castor oil, 0.2 part of hydrolyzed sodium hyaluronate, 0.4 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 0.6 part of peony extract, 1 part of sophora flavescens extract, 0.8 part of sage extract, 1.5 parts of tranexamic acid, 1.1 part of arginine, 2 parts of ascorbic acid, 7 parts of 1, 3-butanediol and 83.1 parts of water.
The preparation method of the whitening and skin-brightening essence comprises the following steps:
(1) Adding nicotinamide, hydrolyzed sodium hyaluronate, p-hydroxyacetophenone, 1, 2-hexanediol, tocopherol acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, tranexamic acid, ascorbic acid and 1, 3-butanediol into water, and stirring uniformly at the rotation speed of 800rpm at the temperature of 80 ℃;
(2) Cooling to 45 deg.C, adding PEG-40 hydrogenated castor oil, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, and arginine, stirring at 800rpm, and cooling to obtain the skin whitening essence.
Comparative example 1
Comparative example 1 is different from example 1 in that comparative example 1 does not contain a peony extract, and the others are the same, wherein the amount of the peony extract is replaced by the equal amount of the sophora flavescens extract and salvia extract, i.e., in this comparative example, the total amount of the peony extract, sophora flavescens extract and salvia extract is not changed, and the others are the same.
The whitening and skin brightening essence comprises the following components in parts by mass: 0.1 part of tocopherol acetate, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of L-arginine ferulate, 0.2 part of decarboxylated carnosine hydrochloride, 0.2 part of PEG-40 hydrogenated castor oil, 0.3 part of hydrolyzed sodium hyaluronate, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 1.2 parts of radix sophorae flavescentis extract, 1.4 parts of sage extract, 1 part of tranexamic acid, 1 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.4 parts of water.
Comparative example 2
Comparative example 2 is different from example 1 in that comparative example 2 does not contain the sophora flavescens extract and is the same except that the amount of the sophora flavescens extract is replaced by the equivalent amount of the paeonia lactiflora extract and the salvia officinalis extract, i.e., the total amount of the paeonia lactiflora extract, the sophora flavescens extract and the salvia officinalis extract is not changed in this comparative example and is the same in all other cases.
The whitening and skin brightening essence comprises the following components in parts by mass: 0.1 part of tocopherol acetate, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of L-arginine ferulate, 0.2 part of decarboxylated carnosine hydrochloride, 0.2 part of PEG-40 hydrogenated castor oil, 0.3 part of hydrolyzed sodium hyaluronate, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 1.2 parts of peony extract, 1.4 parts of sage extract, 1 part of tranexamic acid, 1 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.4 parts of water.
Comparative example 3
Comparative example 3 is different from example 1 in that comparative example 3 does not contain sage extract, and the others are the same, wherein the amount of sage extract is replaced by the same amount of peony extract and sophora flavescens extract, i.e. in this comparative example, the total amount of peony extract, sophora flavescens extract and sage extract is the same, and the others are the same.
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 part of tocopherol acetate, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of L-arginine ferulate, 0.2 part of sarcosine hydrochloride, 0.2 part of PEG-40 hydrogenated castor oil, 0.3 part of hydrolyzed sodium hyaluronate, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 1.3 parts of peony extract, 1.3 parts of sophora flavescens extract, 1 part of tranexamic acid, 1 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.4 parts of water.
Test example
35 volunteers (all women, age 20-28) without skin abnormality are selected, evenly divided into 7 groups, 5 persons in each group respectively try the essence of the examples 1-4 and the essence of the comparative examples 1-3.
Before using the essence, the volunteers all clean the face, and adopt a skin color test probe (Colorimeter CL 400) to collect the brightness (L value) and the skin color individual type angle (ITA degree value) of the face as initial values; after cleansing the face in the morning and evening, the volunteers respectively try the essences of examples 1 to 4 and comparative examples 1 to 3 according to groups, after continuously using the essences for 28 days, try the products and cleanse the face at the 28 th evening, and collect the brightness (L value) and the skin color individual type angle (ITA ° value) of the face by using a skin color test probe (Colorimeter CL 400), as test values, calculate the improvement rate of whiteness and brightness, the L value/ITA ° value improvement rate = (test value-initial value)/initial value, and the test results are shown in table 1.
TABLE 1
| 28d L value increase% | 28d ITA ° value increase% | |
| Example 1 | 3.3 | 5 |
| Example 2 | 2 | 3.8 |
| Example 3 | 2.2 | 3.5 |
| Example 4 | 2.5 | 4.1 |
| Comparative example 1 | 1 | 1.5 |
| Comparative example 2 | 0.7 | 1.1 |
| Comparative example 3 | 0.8 | 1.3 |
As can be seen from table 1, the essence of the present invention has excellent whitening brightness effect, wherein example 1 has the best whitening and skin-lightening effect.
As can be seen from comparative example 1 and comparative examples 1 to 3, the peony extract, the sophora flavescens extract and the salvia officinalis extract have synergistic effects in whitening and brightening the skin.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (10)
1. The whitening and skin-brightening essence is characterized by comprising the following components in parts by mass: 0.1 to 0.25 portion of solubilizer, 0.1 to 0.4 portion of humectant, 0.2 to 0.6 portion of nicotinamide, 0.3 to 0.6 portion of p-hydroxyacetophenone, 0.4 to 1 portion of skin conditioner, 0.4 to 1 portion of 1, 2-hexanediol, 0.4 to 1 portion of peony extract, 0.5 to 1.2 portions of radix sophorae flavescentis extract, 0.5 to 1.2 portions of sage extract, 0.5 to 2 portions of tranexamic acid, 0.5 to 1.2 portions of pH regulator, 1 to 4 portions of antioxidant, 4 to 10 portions of 1, 3-butanediol and 70 to 85 portions of water.
2. The whitening and skin-brightening essence according to claim 1, characterized by comprising the following components in parts by mass: 0.15 to 0.25 portion of solubilizer, 0.2 to 0.4 portion of humectant, 0.3 to 0.6 portion of nicotinamide, 0.4 to 0.6 portion of p-hydroxyacetophenone, 0.4 to 0.8 portion of skin conditioner, 0.5 to 1 portion of 1, 2-hexanediol, 0.5 to 1 portion of peony extract, 0.6 to 1.2 portions of radix sophorae flavescentis extract, 0.8 to 1.2 portions of sage extract, 0.5 to 1.5 portions of tranexamic acid, 0.8 to 1.2 portions of pH regulator, 2 to 4 portions of antioxidant, 4 to 8 portions of 1, 3-butanediol and 75 to 85 portions of water.
3. The whitening and skin-brightening essence according to claim 1, which is characterized by comprising the following components in parts by mass: 0.2 part of solubilizer, 0.3 part of humectant, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.7 part of skin conditioner, 0.8 part of 1, 2-hexanediol, 0.8 part of peony extract, 0.8 part of sophora flavescens extract, 1 part of sage extract, 1 part of tranexamic acid, 1 part of pH regulator, 3 parts of antioxidant, 6 parts of 1, 3-butanediol and 83.4 parts of water.
4. The whitening and skin-lightening essence according to claim 1, wherein the solubilizing agent comprises at least one of PEG-40 hydrogenated castor oil, polyglycerol fatty acid ester, fatty alcohol polyoxyethylene ether, polyoxyethylene sorbitan fatty acid ester.
5. The whitening and skin-lightening essence of claim 1, wherein the skin conditioner comprises at least one of tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxycarnosine hydrochloride, panthenol, biosaccharide-1, oligopeptide-1, tripeptide-1 copper, palmitoyl pentapeptide-4, escin, and glycosphingolipids.
6. The whitening and skin-brightening essence according to claim 1, wherein the pH regulator comprises at least one of arginine, triethanolamine, citric acid and sodium citrate.
7. The whitening and skin-lightening essence according to claim 1, wherein the antioxidant comprises at least one of ascorbic acid, glycerol glucoside, tributyl citrate, pentaerythritol tetrakis (bis-tert-butyl hydroxyhydrocinnamate) ester, and buteth-3.
8. The whitening and skin-brightening essence according to claim 1, wherein the humectant comprises at least one of hydrolyzed sodium hyaluronate, glycerin, propylene glycol, oat beta-glucan, caprylyl glycol, and ethylhexyl glycerin.
9. The preparation method of the whitening and skin-brightening essence of any one of claims 1-8, characterized by comprising the following steps:
(1) Adding nicotinamide, humectant, p-hydroxyacetophenone, 1, 2-hexanediol, skin conditioner, tranexamic acid, antioxidant and 1, 3-butanediol into water, and stirring uniformly at 70-85 ℃;
(2) Cooling to 40-50 ℃, adding a solubilizer, a peony extract, a sophora flavescens extract, a salvia extract and a pH regulator, uniformly stirring, and cooling to obtain the whitening and skin brightening essence.
10. The preparation method of the whitening and skin-brightening essence according to claim 9, wherein the stirring speed in the step (1) is 400-1000 rpm;
the stirring speed in the step (1) is 400-1000 rpm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211470574.6A CN115671001B (en) | 2022-11-25 | 2022-11-25 | Whitening and skin brightening essence and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211470574.6A CN115671001B (en) | 2022-11-25 | 2022-11-25 | Whitening and skin brightening essence and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115671001A true CN115671001A (en) | 2023-02-03 |
| CN115671001B CN115671001B (en) | 2024-03-12 |
Family
ID=85056552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211470574.6A Active CN115671001B (en) | 2022-11-25 | 2022-11-25 | Whitening and skin brightening essence and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115671001B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116650382A (en) * | 2023-07-24 | 2023-08-29 | 广州研智化妆品有限公司 | Tripeptide-1 copper-containing anti-aging repair composition and preparation method and application thereof |
| CN117017820A (en) * | 2023-08-14 | 2023-11-10 | 广州远想生物科技股份有限公司 | Whitening composition and skin care product |
| CN117224444A (en) * | 2023-10-17 | 2023-12-15 | 广州远想生物科技股份有限公司 | Whitening essence and preparation method thereof |
| CN117297991A (en) * | 2023-03-17 | 2023-12-29 | 广州俏姿颜化妆品有限公司 | Multi-targeting whitening and freckle-removing essence and preparation method thereof |
| WO2024192747A1 (en) * | 2023-03-23 | 2024-09-26 | Elc Management Llc | Cosmetic compositions containing decarboxylated oligopeptide and pyracantha extract and methods for treating lipofuscin |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120129598A (en) * | 2011-05-20 | 2012-11-28 | 이상록 | The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage |
| CN106132390A (en) * | 2014-04-03 | 2016-11-16 | 宝丽化成工业有限公司 | The Melanin inhibitor being made up of D pantothenylol and the skin-lightening cosmetic containing this Melanin inhibitor |
| CN110448511A (en) * | 2019-09-06 | 2019-11-15 | 广州留今科学研究有限公司 | The skin conditioning agent of a kind of anticreep adornment and anti-blue light, plain face frost and preparation method thereof |
| CN111297788A (en) * | 2020-04-24 | 2020-06-19 | 广州名门闺秀生物科技有限责任公司 | Whitening and spot-fading essence and preparation method thereof |
| WO2021017835A1 (en) * | 2019-07-30 | 2021-02-04 | 浙江养生堂天然药物研究所有限公司 | Enhanced whitening cosmetic composition |
-
2022
- 2022-11-25 CN CN202211470574.6A patent/CN115671001B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120129598A (en) * | 2011-05-20 | 2012-11-28 | 이상록 | The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage |
| CN106132390A (en) * | 2014-04-03 | 2016-11-16 | 宝丽化成工业有限公司 | The Melanin inhibitor being made up of D pantothenylol and the skin-lightening cosmetic containing this Melanin inhibitor |
| WO2021017835A1 (en) * | 2019-07-30 | 2021-02-04 | 浙江养生堂天然药物研究所有限公司 | Enhanced whitening cosmetic composition |
| CN110448511A (en) * | 2019-09-06 | 2019-11-15 | 广州留今科学研究有限公司 | The skin conditioning agent of a kind of anticreep adornment and anti-blue light, plain face frost and preparation method thereof |
| CN111297788A (en) * | 2020-04-24 | 2020-06-19 | 广州名门闺秀生物科技有限责任公司 | Whitening and spot-fading essence and preparation method thereof |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117297991A (en) * | 2023-03-17 | 2023-12-29 | 广州俏姿颜化妆品有限公司 | Multi-targeting whitening and freckle-removing essence and preparation method thereof |
| WO2024192747A1 (en) * | 2023-03-23 | 2024-09-26 | Elc Management Llc | Cosmetic compositions containing decarboxylated oligopeptide and pyracantha extract and methods for treating lipofuscin |
| CN116650382A (en) * | 2023-07-24 | 2023-08-29 | 广州研智化妆品有限公司 | Tripeptide-1 copper-containing anti-aging repair composition and preparation method and application thereof |
| CN116650382B (en) * | 2023-07-24 | 2023-12-26 | 广州研智化妆品有限公司 | Tripeptide-1 copper-containing anti-aging repair composition and preparation method and application thereof |
| CN117017820A (en) * | 2023-08-14 | 2023-11-10 | 广州远想生物科技股份有限公司 | Whitening composition and skin care product |
| CN117224444A (en) * | 2023-10-17 | 2023-12-15 | 广州远想生物科技股份有限公司 | Whitening essence and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115671001B (en) | 2024-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115671001A (en) | Whitening and skin-brightening essence and preparation method thereof | |
| CN103830152B (en) | There is cosmetic composition and the essence of whitening function | |
| CN111529477A (en) | Composition for caring hair, and preparation and application thereof | |
| CN112315864A (en) | Whitening and brightening composition and preparation method thereof | |
| KR101396438B1 (en) | Composition for improving scalp and hair condition containing the complex extracts of persimmon, camellia sinensis leaf and carob bean | |
| CN113425639A (en) | Antioxidant composition, application thereof and product | |
| KR20170137564A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| JP2002104924A (en) | Photo aging-preventing agent | |
| KR20170137553A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR101799155B1 (en) | External preparation for skin comprising extract of Traditional herb | |
| CN112618396A (en) | A cosmetic prepared from bakuchiol | |
| CN112266825A (en) | Compound essential oil, preparation method thereof and application of compound essential oil in whitening and anti-wrinkle cosmetics | |
| CN114869817B (en) | Composition with whitening effect and preparation method thereof | |
| CN115227620A (en) | Nourishing and moisturizing skin brightening lotion and preparation method thereof | |
| CN113116765B (en) | Essence stock solution, preparation method thereof and collagenase inhibitor | |
| KR102146522B1 (en) | Composition of natural preservatives for cosmetic and cosmetic composition comprising the same | |
| CN110090193B (en) | Acne-removing moisturizing essence with fat-reducing effect and preparation method thereof | |
| KR20150081221A (en) | Cosmetic composition for improving anti-wrinkle containing the extract mori radicis cortex, Lindera obtusiloba and Lespedeza cuneata | |
| KR102139778B1 (en) | Composition for Anti-inflammatory, Skin Whitening, Skin Cell Regeneration, and Anti-Wrinkling Activity Comprising Complex Extract of Plectranthus tomentosa as Active Ingredient | |
| KR20170136933A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR20170137548A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| CN112494408A (en) | Whitening and inflammation diminishing mask liquid and preparation method thereof | |
| CN112043650A (en) | Acne-removing repairing cosmetic preparation and preparation method thereof | |
| KR20090068397A (en) | Cosmetic composition with the effect of calming skins | |
| CN114748389B (en) | Essence liquid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |